LGND7:00 AMLigand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregatorligand.com
LGND7:00 AMLigand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGSligand.com
LGND7:00 AMLigand Advances Strategic Growth with Expanded and Strengthened Business Development Teamligand.com